International Journal of Clinical Medicine

Volume 2, Issue 4 (September 2011)

ISSN Print: 2158-284X   ISSN Online: 2158-2882

Google-based Impact Factor: 0.62  Citations  h5-index & Ranking

Cholecystokinin in the Pathogenesis of Bulimia Nervosa

HTML  Download Download as PDF (Size: 134KB)  PP. 509-515  
DOI: 10.4236/ijcm.2011.24085    4,804 Downloads   7,997 Views  Citations




Objective: This review aims to describe the role of the hormone cholecystokinin (CCK) in the pathogenesis of bulimia nervosa (BN), the perpetuation of this illness and the possibility of its use as a target for future therapeutic advances. Methods: Search for cholecystokinin AND bulimia nervosa in Pubmed Central, with no limits, identified 38 articles published up to the present date. Results: It is well established that CCK is altered in the pathogenesis of BN, and that its main role is in the perpetuation of the disorder rather than the cause of it. Discussion: Additional studies will be needed to further understand the mechanisms by which CCK regulates orexigenic pathways. If an orally active, longer acting analogue of CCK could be developed, it would be of significant interest as an appetite suppressant and a key adjuvant in the treatment of patients suffering from BN, particularly in refractory cases.

Share and Cite:

H. López, R. Molina-Ruiz, L. Molón and M. Díaz-Marsá, "Cholecystokinin in the Pathogenesis of Bulimia Nervosa," International Journal of Clinical Medicine, Vol. 2 No. 4, 2011, pp. 509-515. doi: 10.4236/ijcm.2011.24085.

Cited by

[1] Gastrointestinal Hormones
Gastrointestinal Physiology, 2018

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.